Amili
Gwendoline Tan is an experienced professional currently serving as the Chief Strategy Officer at Singapore Precision Medicine Pte Ltd since February 2018. Prior to this role, Gwendoline held prominent positions at the National University Health System, including Head of Research Administration & Strategy, Research Strategy, and Research Policy and Planning from October 2014 to February 2018. Gwendoline also contributed to Nanyang Polytechnic as Manager of Corporate Planning from 2011 to February 2018. Academic credentials include a Doctor of Business Administration from Southern Cross University and a Master of Business Administration from Victoria University.
This person is not in any offices
Amili
Asian Microbiome Library (AMILI) is Southeast Asia’s first precision gut microbiome company and only stool bank serving as a hub for gut microbiome innovation and therapy. Their aim is to advance microbiome research, grounded in science and compassion, to address unmet and critical needs in healthcare with the potential to positively impact millions of lives across Asia.